(Reuters) - Drug developer Inovio Pharmaceuticals Inc said preclinical testing of its vaccine for Zika virus induced robust and durable response in mice and it expected to test the vaccine in humans before the end of 2016.
http://ift.tt/xePdMM
from Reuters: Health News
via animenewspro
Aucun commentaire:
Enregistrer un commentaire